Global Pulmonary Surfactant Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Pulmonary Surfactant Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 118

Published Date: 08 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Pulmonary surfactant is a mixture of lipids and proteins which is secreted into the alveolar space by epithelial type II cells. The main function of surfactant is to lower the surface tension at the air/liquid interface within the alveoli of the lung.

According to our (Global Info Research) latest study, the global Pulmonary Surfactant market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Pulmonary Surfactant market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Pulmonary Surfactant market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Pulmonary Surfactant market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Pulmonary Surfactant market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Pulmonary Surfactant market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pulmonary Surfactant
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pulmonary Surfactant market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, AbbVie, Lyomark Pharma, Tekzima (Noargen) and ONY Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Pulmonary Surfactant market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Synthetic Pulmonary Surfactants
Animal Derived Surfactants

Market segment by Application
Hospital
laboratory
Others

Major players covered
Boehringer Ingelheim
AbbVie
Lyomark Pharma
Tekzima (Noargen)
ONY Biotech
Abbott
Aviva Systems Biology
LSBio
Biomatik
Biorbyt
Reddot Biotech
XpressBio
Creative Diagnostics
Nanjing Norris Pharm Technology
Windtree Therapeutics

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pulmonary Surfactant product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pulmonary Surfactant, with price, sales, revenue and global market share of Pulmonary Surfactant from 2018 to 2023.
Chapter 3, the Pulmonary Surfactant competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Surfactant breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pulmonary Surfactant market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pulmonary Surfactant.
Chapter 14 and 15, to describe Pulmonary Surfactant sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Pulmonary Surfactant
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pulmonary Surfactant Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Synthetic Pulmonary Surfactants
1.3.3 Animal Derived Surfactants
1.4 Market Analysis by Application
1.4.1 Overview: Global Pulmonary Surfactant Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 laboratory
1.4.4 Others
1.5 Global Pulmonary Surfactant Market Size & Forecast
1.5.1 Global Pulmonary Surfactant Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pulmonary Surfactant Sales Quantity (2018-2029)
1.5.3 Global Pulmonary Surfactant Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Pulmonary Surfactant Product and Services
2.1.4 Boehringer Ingelheim Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Boehringer Ingelheim Recent Developments/Updates
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Pulmonary Surfactant Product and Services
2.2.4 AbbVie Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AbbVie Recent Developments/Updates
2.3 Lyomark Pharma
2.3.1 Lyomark Pharma Details
2.3.2 Lyomark Pharma Major Business
2.3.3 Lyomark Pharma Pulmonary Surfactant Product and Services
2.3.4 Lyomark Pharma Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Lyomark Pharma Recent Developments/Updates
2.4 Tekzima (Noargen)
2.4.1 Tekzima (Noargen) Details
2.4.2 Tekzima (Noargen) Major Business
2.4.3 Tekzima (Noargen) Pulmonary Surfactant Product and Services
2.4.4 Tekzima (Noargen) Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Tekzima (Noargen) Recent Developments/Updates
2.5 ONY Biotech
2.5.1 ONY Biotech Details
2.5.2 ONY Biotech Major Business
2.5.3 ONY Biotech Pulmonary Surfactant Product and Services
2.5.4 ONY Biotech Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 ONY Biotech Recent Developments/Updates
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Pulmonary Surfactant Product and Services
2.6.4 Abbott Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Abbott Recent Developments/Updates
2.7 Aviva Systems Biology
2.7.1 Aviva Systems Biology Details
2.7.2 Aviva Systems Biology Major Business
2.7.3 Aviva Systems Biology Pulmonary Surfactant Product and Services
2.7.4 Aviva Systems Biology Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Aviva Systems Biology Recent Developments/Updates
2.8 LSBio
2.8.1 LSBio Details
2.8.2 LSBio Major Business
2.8.3 LSBio Pulmonary Surfactant Product and Services
2.8.4 LSBio Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 LSBio Recent Developments/Updates
2.9 Biomatik
2.9.1 Biomatik Details
2.9.2 Biomatik Major Business
2.9.3 Biomatik Pulmonary Surfactant Product and Services
2.9.4 Biomatik Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Biomatik Recent Developments/Updates
2.10 Biorbyt
2.10.1 Biorbyt Details
2.10.2 Biorbyt Major Business
2.10.3 Biorbyt Pulmonary Surfactant Product and Services
2.10.4 Biorbyt Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Biorbyt Recent Developments/Updates
2.11 Reddot Biotech
2.11.1 Reddot Biotech Details
2.11.2 Reddot Biotech Major Business
2.11.3 Reddot Biotech Pulmonary Surfactant Product and Services
2.11.4 Reddot Biotech Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Reddot Biotech Recent Developments/Updates
2.12 XpressBio
2.12.1 XpressBio Details
2.12.2 XpressBio Major Business
2.12.3 XpressBio Pulmonary Surfactant Product and Services
2.12.4 XpressBio Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 XpressBio Recent Developments/Updates
2.13 Creative Diagnostics
2.13.1 Creative Diagnostics Details
2.13.2 Creative Diagnostics Major Business
2.13.3 Creative Diagnostics Pulmonary Surfactant Product and Services
2.13.4 Creative Diagnostics Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Creative Diagnostics Recent Developments/Updates
2.14 Nanjing Norris Pharm Technology
2.14.1 Nanjing Norris Pharm Technology Details
2.14.2 Nanjing Norris Pharm Technology Major Business
2.14.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Product and Services
2.14.4 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Nanjing Norris Pharm Technology Recent Developments/Updates
2.15 Windtree Therapeutics
2.15.1 Windtree Therapeutics Details
2.15.2 Windtree Therapeutics Major Business
2.15.3 Windtree Therapeutics Pulmonary Surfactant Product and Services
2.15.4 Windtree Therapeutics Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Windtree Therapeutics Recent Developments/Updates

3 Competitive Environment: Pulmonary Surfactant by Manufacturer
3.1 Global Pulmonary Surfactant Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pulmonary Surfactant Revenue by Manufacturer (2018-2023)
3.3 Global Pulmonary Surfactant Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pulmonary Surfactant by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pulmonary Surfactant Manufacturer Market Share in 2022
3.4.2 Top 6 Pulmonary Surfactant Manufacturer Market Share in 2022
3.5 Pulmonary Surfactant Market: Overall Company Footprint Analysis
3.5.1 Pulmonary Surfactant Market: Region Footprint
3.5.2 Pulmonary Surfactant Market: Company Product Type Footprint
3.5.3 Pulmonary Surfactant Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Pulmonary Surfactant Market Size by Region
4.1.1 Global Pulmonary Surfactant Sales Quantity by Region (2018-2029)
4.1.2 Global Pulmonary Surfactant Consumption Value by Region (2018-2029)
4.1.3 Global Pulmonary Surfactant Average Price by Region (2018-2029)
4.2 North America Pulmonary Surfactant Consumption Value (2018-2029)
4.3 Europe Pulmonary Surfactant Consumption Value (2018-2029)
4.4 Asia-Pacific Pulmonary Surfactant Consumption Value (2018-2029)
4.5 South America Pulmonary Surfactant Consumption Value (2018-2029)
4.6 Middle East and Africa Pulmonary Surfactant Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Pulmonary Surfactant Sales Quantity by Type (2018-2029)
5.2 Global Pulmonary Surfactant Consumption Value by Type (2018-2029)
5.3 Global Pulmonary Surfactant Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Pulmonary Surfactant Sales Quantity by Application (2018-2029)
6.2 Global Pulmonary Surfactant Consumption Value by Application (2018-2029)
6.3 Global Pulmonary Surfactant Average Price by Application (2018-2029)

7 North America
7.1 North America Pulmonary Surfactant Sales Quantity by Type (2018-2029)
7.2 North America Pulmonary Surfactant Sales Quantity by Application (2018-2029)
7.3 North America Pulmonary Surfactant Market Size by Country
7.3.1 North America Pulmonary Surfactant Sales Quantity by Country (2018-2029)
7.3.2 North America Pulmonary Surfactant Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Pulmonary Surfactant Sales Quantity by Type (2018-2029)
8.2 Europe Pulmonary Surfactant Sales Quantity by Application (2018-2029)
8.3 Europe Pulmonary Surfactant Market Size by Country
8.3.1 Europe Pulmonary Surfactant Sales Quantity by Country (2018-2029)
8.3.2 Europe Pulmonary Surfactant Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Pulmonary Surfactant Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pulmonary Surfactant Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pulmonary Surfactant Market Size by Region
9.3.1 Asia-Pacific Pulmonary Surfactant Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pulmonary Surfactant Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Pulmonary Surfactant Sales Quantity by Type (2018-2029)
10.2 South America Pulmonary Surfactant Sales Quantity by Application (2018-2029)
10.3 South America Pulmonary Surfactant Market Size by Country
10.3.1 South America Pulmonary Surfactant Sales Quantity by Country (2018-2029)
10.3.2 South America Pulmonary Surfactant Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Pulmonary Surfactant Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pulmonary Surfactant Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pulmonary Surfactant Market Size by Country
11.3.1 Middle East & Africa Pulmonary Surfactant Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pulmonary Surfactant Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Pulmonary Surfactant Market Drivers
12.2 Pulmonary Surfactant Market Restraints
12.3 Pulmonary Surfactant Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Pulmonary Surfactant and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pulmonary Surfactant
13.3 Pulmonary Surfactant Production Process
13.4 Pulmonary Surfactant Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pulmonary Surfactant Typical Distributors
14.3 Pulmonary Surfactant Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Pulmonary Surfactant Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pulmonary Surfactant Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim Major Business
Table 5. Boehringer Ingelheim Pulmonary Surfactant Product and Services
Table 6. Boehringer Ingelheim Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Boehringer Ingelheim Recent Developments/Updates
Table 8. AbbVie Basic Information, Manufacturing Base and Competitors
Table 9. AbbVie Major Business
Table 10. AbbVie Pulmonary Surfactant Product and Services
Table 11. AbbVie Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AbbVie Recent Developments/Updates
Table 13. Lyomark Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Lyomark Pharma Major Business
Table 15. Lyomark Pharma Pulmonary Surfactant Product and Services
Table 16. Lyomark Pharma Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Lyomark Pharma Recent Developments/Updates
Table 18. Tekzima (Noargen) Basic Information, Manufacturing Base and Competitors
Table 19. Tekzima (Noargen) Major Business
Table 20. Tekzima (Noargen) Pulmonary Surfactant Product and Services
Table 21. Tekzima (Noargen) Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Tekzima (Noargen) Recent Developments/Updates
Table 23. ONY Biotech Basic Information, Manufacturing Base and Competitors
Table 24. ONY Biotech Major Business
Table 25. ONY Biotech Pulmonary Surfactant Product and Services
Table 26. ONY Biotech Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. ONY Biotech Recent Developments/Updates
Table 28. Abbott Basic Information, Manufacturing Base and Competitors
Table 29. Abbott Major Business
Table 30. Abbott Pulmonary Surfactant Product and Services
Table 31. Abbott Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Abbott Recent Developments/Updates
Table 33. Aviva Systems Biology Basic Information, Manufacturing Base and Competitors
Table 34. Aviva Systems Biology Major Business
Table 35. Aviva Systems Biology Pulmonary Surfactant Product and Services
Table 36. Aviva Systems Biology Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Aviva Systems Biology Recent Developments/Updates
Table 38. LSBio Basic Information, Manufacturing Base and Competitors
Table 39. LSBio Major Business
Table 40. LSBio Pulmonary Surfactant Product and Services
Table 41. LSBio Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. LSBio Recent Developments/Updates
Table 43. Biomatik Basic Information, Manufacturing Base and Competitors
Table 44. Biomatik Major Business
Table 45. Biomatik Pulmonary Surfactant Product and Services
Table 46. Biomatik Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Biomatik Recent Developments/Updates
Table 48. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 49. Biorbyt Major Business
Table 50. Biorbyt Pulmonary Surfactant Product and Services
Table 51. Biorbyt Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Biorbyt Recent Developments/Updates
Table 53. Reddot Biotech Basic Information, Manufacturing Base and Competitors
Table 54. Reddot Biotech Major Business
Table 55. Reddot Biotech Pulmonary Surfactant Product and Services
Table 56. Reddot Biotech Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Reddot Biotech Recent Developments/Updates
Table 58. XpressBio Basic Information, Manufacturing Base and Competitors
Table 59. XpressBio Major Business
Table 60. XpressBio Pulmonary Surfactant Product and Services
Table 61. XpressBio Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. XpressBio Recent Developments/Updates
Table 63. Creative Diagnostics Basic Information, Manufacturing Base and Competitors
Table 64. Creative Diagnostics Major Business
Table 65. Creative Diagnostics Pulmonary Surfactant Product and Services
Table 66. Creative Diagnostics Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Creative Diagnostics Recent Developments/Updates
Table 68. Nanjing Norris Pharm Technology Basic Information, Manufacturing Base and Competitors
Table 69. Nanjing Norris Pharm Technology Major Business
Table 70. Nanjing Norris Pharm Technology Pulmonary Surfactant Product and Services
Table 71. Nanjing Norris Pharm Technology Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Nanjing Norris Pharm Technology Recent Developments/Updates
Table 73. Windtree Therapeutics Basic Information, Manufacturing Base and Competitors
Table 74. Windtree Therapeutics Major Business
Table 75. Windtree Therapeutics Pulmonary Surfactant Product and Services
Table 76. Windtree Therapeutics Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Windtree Therapeutics Recent Developments/Updates
Table 78. Global Pulmonary Surfactant Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Pulmonary Surfactant Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Pulmonary Surfactant Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 81. Market Position of Manufacturers in Pulmonary Surfactant, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Pulmonary Surfactant Production Site of Key Manufacturer
Table 83. Pulmonary Surfactant Market: Company Product Type Footprint
Table 84. Pulmonary Surfactant Market: Company Product Application Footprint
Table 85. Pulmonary Surfactant New Market Entrants and Barriers to Market Entry
Table 86. Pulmonary Surfactant Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Pulmonary Surfactant Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Pulmonary Surfactant Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Pulmonary Surfactant Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Pulmonary Surfactant Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Pulmonary Surfactant Average Price by Region (2018-2023) & (USD/Unit)
Table 92. Global Pulmonary Surfactant Average Price by Region (2024-2029) & (USD/Unit)
Table 93. Global Pulmonary Surfactant Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Pulmonary Surfactant Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Pulmonary Surfactant Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Pulmonary Surfactant Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Pulmonary Surfactant Average Price by Type (2018-2023) & (USD/Unit)
Table 98. Global Pulmonary Surfactant Average Price by Type (2024-2029) & (USD/Unit)
Table 99. Global Pulmonary Surfactant Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Pulmonary Surfactant Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Pulmonary Surfactant Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Pulmonary Surfactant Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Pulmonary Surfactant Average Price by Application (2018-2023) & (USD/Unit)
Table 104. Global Pulmonary Surfactant Average Price by Application (2024-2029) & (USD/Unit)
Table 105. North America Pulmonary Surfactant Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Pulmonary Surfactant Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Pulmonary Surfactant Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Pulmonary Surfactant Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Pulmonary Surfactant Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Pulmonary Surfactant Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Pulmonary Surfactant Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Pulmonary Surfactant Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Pulmonary Surfactant Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Pulmonary Surfactant Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Pulmonary Surfactant Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Pulmonary Surfactant Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Pulmonary Surfactant Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Pulmonary Surfactant Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Pulmonary Surfactant Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Pulmonary Surfactant Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Pulmonary Surfactant Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Pulmonary Surfactant Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Pulmonary Surfactant Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Pulmonary Surfactant Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Pulmonary Surfactant Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Pulmonary Surfactant Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Pulmonary Surfactant Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Pulmonary Surfactant Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Pulmonary Surfactant Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Pulmonary Surfactant Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Pulmonary Surfactant Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Pulmonary Surfactant Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Pulmonary Surfactant Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Pulmonary Surfactant Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Pulmonary Surfactant Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Pulmonary Surfactant Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Pulmonary Surfactant Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Pulmonary Surfactant Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Pulmonary Surfactant Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Pulmonary Surfactant Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Pulmonary Surfactant Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Pulmonary Surfactant Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Pulmonary Surfactant Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Pulmonary Surfactant Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Pulmonary Surfactant Raw Material
Table 146. Key Manufacturers of Pulmonary Surfactant Raw Materials
Table 147. Pulmonary Surfactant Typical Distributors
Table 148. Pulmonary Surfactant Typical Customers
List of Figures
Figure 1. Pulmonary Surfactant Picture
Figure 2. Global Pulmonary Surfactant Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pulmonary Surfactant Consumption Value Market Share by Type in 2022
Figure 4. Synthetic Pulmonary Surfactants Examples
Figure 5. Animal Derived Surfactants Examples
Figure 6. Global Pulmonary Surfactant Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Pulmonary Surfactant Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. laboratory Examples
Figure 10. Others Examples
Figure 11. Global Pulmonary Surfactant Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Pulmonary Surfactant Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Pulmonary Surfactant Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Pulmonary Surfactant Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Pulmonary Surfactant Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Pulmonary Surfactant Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Pulmonary Surfactant by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Pulmonary Surfactant Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Pulmonary Surfactant Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Pulmonary Surfactant Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Pulmonary Surfactant Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Pulmonary Surfactant Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Pulmonary Surfactant Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Pulmonary Surfactant Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Pulmonary Surfactant Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Pulmonary Surfactant Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Pulmonary Surfactant Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Pulmonary Surfactant Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Pulmonary Surfactant Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Pulmonary Surfactant Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Pulmonary Surfactant Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Pulmonary Surfactant Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Pulmonary Surfactant Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Pulmonary Surfactant Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Pulmonary Surfactant Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Pulmonary Surfactant Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Pulmonary Surfactant Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Pulmonary Surfactant Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Pulmonary Surfactant Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Pulmonary Surfactant Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Pulmonary Surfactant Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Pulmonary Surfactant Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Pulmonary Surfactant Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Pulmonary Surfactant Consumption Value Market Share by Region (2018-2029)
Figure 53. China Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Pulmonary Surfactant Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Pulmonary Surfactant Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Pulmonary Surfactant Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Pulmonary Surfactant Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Pulmonary Surfactant Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Pulmonary Surfactant Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Pulmonary Surfactant Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Pulmonary Surfactant Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Pulmonary Surfactant Market Drivers
Figure 74. Pulmonary Surfactant Market Restraints
Figure 75. Pulmonary Surfactant Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Pulmonary Surfactant in 2022
Figure 78. Manufacturing Process Analysis of Pulmonary Surfactant
Figure 79. Pulmonary Surfactant Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Boehringer Ingelheim
AbbVie
Lyomark Pharma
Tekzima (Noargen)
ONY Biotech
Abbott
Aviva Systems Biology
LSBio
Biomatik
Biorbyt
Reddot Biotech
XpressBio
Creative Diagnostics
Nanjing Norris Pharm Technology
Windtree Therapeutics
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Pulmonary Surfactant Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Pulmonary Surfactant Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 118

Published Date: 08 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Pulmonary surfactant is a mixture of lipids and proteins which is secreted into the alveolar space by epithelial type II cells. The main function of surfactant is to lower the surface tension at the air/liquid interface within the alveoli of the lung.

According to our (Global Info Research) latest study, the global Pulmonary Surfactant market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Pulmonary Surfactant market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Pulmonary Surfactant market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Pulmonary Surfactant market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Pulmonary Surfactant market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Pulmonary Surfactant market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pulmonary Surfactant
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pulmonary Surfactant market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, AbbVie, Lyomark Pharma, Tekzima (Noargen) and ONY Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Pulmonary Surfactant market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Synthetic Pulmonary Surfactants
Animal Derived Surfactants

Market segment by Application
Hospital
laboratory
Others

Major players covered
Boehringer Ingelheim
AbbVie
Lyomark Pharma
Tekzima (Noargen)
ONY Biotech
Abbott
Aviva Systems Biology
LSBio
Biomatik
Biorbyt
Reddot Biotech
XpressBio
Creative Diagnostics
Nanjing Norris Pharm Technology
Windtree Therapeutics

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pulmonary Surfactant product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pulmonary Surfactant, with price, sales, revenue and global market share of Pulmonary Surfactant from 2018 to 2023.
Chapter 3, the Pulmonary Surfactant competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Surfactant breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pulmonary Surfactant market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pulmonary Surfactant.
Chapter 14 and 15, to describe Pulmonary Surfactant sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Pulmonary Surfactant
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pulmonary Surfactant Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Synthetic Pulmonary Surfactants
1.3.3 Animal Derived Surfactants
1.4 Market Analysis by Application
1.4.1 Overview: Global Pulmonary Surfactant Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 laboratory
1.4.4 Others
1.5 Global Pulmonary Surfactant Market Size & Forecast
1.5.1 Global Pulmonary Surfactant Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pulmonary Surfactant Sales Quantity (2018-2029)
1.5.3 Global Pulmonary Surfactant Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Pulmonary Surfactant Product and Services
2.1.4 Boehringer Ingelheim Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Boehringer Ingelheim Recent Developments/Updates
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Pulmonary Surfactant Product and Services
2.2.4 AbbVie Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AbbVie Recent Developments/Updates
2.3 Lyomark Pharma
2.3.1 Lyomark Pharma Details
2.3.2 Lyomark Pharma Major Business
2.3.3 Lyomark Pharma Pulmonary Surfactant Product and Services
2.3.4 Lyomark Pharma Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Lyomark Pharma Recent Developments/Updates
2.4 Tekzima (Noargen)
2.4.1 Tekzima (Noargen) Details
2.4.2 Tekzima (Noargen) Major Business
2.4.3 Tekzima (Noargen) Pulmonary Surfactant Product and Services
2.4.4 Tekzima (Noargen) Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Tekzima (Noargen) Recent Developments/Updates
2.5 ONY Biotech
2.5.1 ONY Biotech Details
2.5.2 ONY Biotech Major Business
2.5.3 ONY Biotech Pulmonary Surfactant Product and Services
2.5.4 ONY Biotech Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 ONY Biotech Recent Developments/Updates
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Pulmonary Surfactant Product and Services
2.6.4 Abbott Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Abbott Recent Developments/Updates
2.7 Aviva Systems Biology
2.7.1 Aviva Systems Biology Details
2.7.2 Aviva Systems Biology Major Business
2.7.3 Aviva Systems Biology Pulmonary Surfactant Product and Services
2.7.4 Aviva Systems Biology Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Aviva Systems Biology Recent Developments/Updates
2.8 LSBio
2.8.1 LSBio Details
2.8.2 LSBio Major Business
2.8.3 LSBio Pulmonary Surfactant Product and Services
2.8.4 LSBio Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 LSBio Recent Developments/Updates
2.9 Biomatik
2.9.1 Biomatik Details
2.9.2 Biomatik Major Business
2.9.3 Biomatik Pulmonary Surfactant Product and Services
2.9.4 Biomatik Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Biomatik Recent Developments/Updates
2.10 Biorbyt
2.10.1 Biorbyt Details
2.10.2 Biorbyt Major Business
2.10.3 Biorbyt Pulmonary Surfactant Product and Services
2.10.4 Biorbyt Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Biorbyt Recent Developments/Updates
2.11 Reddot Biotech
2.11.1 Reddot Biotech Details
2.11.2 Reddot Biotech Major Business
2.11.3 Reddot Biotech Pulmonary Surfactant Product and Services
2.11.4 Reddot Biotech Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Reddot Biotech Recent Developments/Updates
2.12 XpressBio
2.12.1 XpressBio Details
2.12.2 XpressBio Major Business
2.12.3 XpressBio Pulmonary Surfactant Product and Services
2.12.4 XpressBio Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 XpressBio Recent Developments/Updates
2.13 Creative Diagnostics
2.13.1 Creative Diagnostics Details
2.13.2 Creative Diagnostics Major Business
2.13.3 Creative Diagnostics Pulmonary Surfactant Product and Services
2.13.4 Creative Diagnostics Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Creative Diagnostics Recent Developments/Updates
2.14 Nanjing Norris Pharm Technology
2.14.1 Nanjing Norris Pharm Technology Details
2.14.2 Nanjing Norris Pharm Technology Major Business
2.14.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Product and Services
2.14.4 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Nanjing Norris Pharm Technology Recent Developments/Updates
2.15 Windtree Therapeutics
2.15.1 Windtree Therapeutics Details
2.15.2 Windtree Therapeutics Major Business
2.15.3 Windtree Therapeutics Pulmonary Surfactant Product and Services
2.15.4 Windtree Therapeutics Pulmonary Surfactant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Windtree Therapeutics Recent Developments/Updates

3 Competitive Environment: Pulmonary Surfactant by Manufacturer
3.1 Global Pulmonary Surfactant Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pulmonary Surfactant Revenue by Manufacturer (2018-2023)
3.3 Global Pulmonary Surfactant Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pulmonary Surfactant by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pulmonary Surfactant Manufacturer Market Share in 2022
3.4.2 Top 6 Pulmonary Surfactant Manufacturer Market Share in 2022
3.5 Pulmonary Surfactant Market: Overall Company Footprint Analysis
3.5.1 Pulmonary Surfactant Market: Region Footprint
3.5.2 Pulmonary Surfactant Market: Company Product Type Footprint
3.5.3 Pulmonary Surfactant Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Pulmonary Surfactant Market Size by Region
4.1.1 Global Pulmonary Surfactant Sales Quantity by Region (2018-2029)
4.1.2 Global Pulmonary Surfactant Consumption Value by Region (2018-2029)
4.1.3 Global Pulmonary Surfactant Average Price by Region (2018-2029)
4.2 North America Pulmonary Surfactant Consumption Value (2018-2029)
4.3 Europe Pulmonary Surfactant Consumption Value (2018-2029)
4.4 Asia-Pacific Pulmonary Surfactant Consumption Value (2018-2029)
4.5 South America Pulmonary Surfactant Consumption Value (2018-2029)
4.6 Middle East and Africa Pulmonary Surfactant Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Pulmonary Surfactant Sales Quantity by Type (2018-2029)
5.2 Global Pulmonary Surfactant Consumption Value by Type (2018-2029)
5.3 Global Pulmonary Surfactant Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Pulmonary Surfactant Sales Quantity by Application (2018-2029)
6.2 Global Pulmonary Surfactant Consumption Value by Application (2018-2029)
6.3 Global Pulmonary Surfactant Average Price by Application (2018-2029)

7 North America
7.1 North America Pulmonary Surfactant Sales Quantity by Type (2018-2029)
7.2 North America Pulmonary Surfactant Sales Quantity by Application (2018-2029)
7.3 North America Pulmonary Surfactant Market Size by Country
7.3.1 North America Pulmonary Surfactant Sales Quantity by Country (2018-2029)
7.3.2 North America Pulmonary Surfactant Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Pulmonary Surfactant Sales Quantity by Type (2018-2029)
8.2 Europe Pulmonary Surfactant Sales Quantity by Application (2018-2029)
8.3 Europe Pulmonary Surfactant Market Size by Country
8.3.1 Europe Pulmonary Surfactant Sales Quantity by Country (2018-2029)
8.3.2 Europe Pulmonary Surfactant Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Pulmonary Surfactant Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pulmonary Surfactant Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pulmonary Surfactant Market Size by Region
9.3.1 Asia-Pacific Pulmonary Surfactant Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pulmonary Surfactant Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Pulmonary Surfactant Sales Quantity by Type (2018-2029)
10.2 South America Pulmonary Surfactant Sales Quantity by Application (2018-2029)
10.3 South America Pulmonary Surfactant Market Size by Country
10.3.1 South America Pulmonary Surfactant Sales Quantity by Country (2018-2029)
10.3.2 South America Pulmonary Surfactant Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Pulmonary Surfactant Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pulmonary Surfactant Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pulmonary Surfactant Market Size by Country
11.3.1 Middle East & Africa Pulmonary Surfactant Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pulmonary Surfactant Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Pulmonary Surfactant Market Drivers
12.2 Pulmonary Surfactant Market Restraints
12.3 Pulmonary Surfactant Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Pulmonary Surfactant and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pulmonary Surfactant
13.3 Pulmonary Surfactant Production Process
13.4 Pulmonary Surfactant Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pulmonary Surfactant Typical Distributors
14.3 Pulmonary Surfactant Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Pulmonary Surfactant Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pulmonary Surfactant Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim Major Business
Table 5. Boehringer Ingelheim Pulmonary Surfactant Product and Services
Table 6. Boehringer Ingelheim Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Boehringer Ingelheim Recent Developments/Updates
Table 8. AbbVie Basic Information, Manufacturing Base and Competitors
Table 9. AbbVie Major Business
Table 10. AbbVie Pulmonary Surfactant Product and Services
Table 11. AbbVie Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AbbVie Recent Developments/Updates
Table 13. Lyomark Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Lyomark Pharma Major Business
Table 15. Lyomark Pharma Pulmonary Surfactant Product and Services
Table 16. Lyomark Pharma Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Lyomark Pharma Recent Developments/Updates
Table 18. Tekzima (Noargen) Basic Information, Manufacturing Base and Competitors
Table 19. Tekzima (Noargen) Major Business
Table 20. Tekzima (Noargen) Pulmonary Surfactant Product and Services
Table 21. Tekzima (Noargen) Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Tekzima (Noargen) Recent Developments/Updates
Table 23. ONY Biotech Basic Information, Manufacturing Base and Competitors
Table 24. ONY Biotech Major Business
Table 25. ONY Biotech Pulmonary Surfactant Product and Services
Table 26. ONY Biotech Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. ONY Biotech Recent Developments/Updates
Table 28. Abbott Basic Information, Manufacturing Base and Competitors
Table 29. Abbott Major Business
Table 30. Abbott Pulmonary Surfactant Product and Services
Table 31. Abbott Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Abbott Recent Developments/Updates
Table 33. Aviva Systems Biology Basic Information, Manufacturing Base and Competitors
Table 34. Aviva Systems Biology Major Business
Table 35. Aviva Systems Biology Pulmonary Surfactant Product and Services
Table 36. Aviva Systems Biology Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Aviva Systems Biology Recent Developments/Updates
Table 38. LSBio Basic Information, Manufacturing Base and Competitors
Table 39. LSBio Major Business
Table 40. LSBio Pulmonary Surfactant Product and Services
Table 41. LSBio Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. LSBio Recent Developments/Updates
Table 43. Biomatik Basic Information, Manufacturing Base and Competitors
Table 44. Biomatik Major Business
Table 45. Biomatik Pulmonary Surfactant Product and Services
Table 46. Biomatik Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Biomatik Recent Developments/Updates
Table 48. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 49. Biorbyt Major Business
Table 50. Biorbyt Pulmonary Surfactant Product and Services
Table 51. Biorbyt Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Biorbyt Recent Developments/Updates
Table 53. Reddot Biotech Basic Information, Manufacturing Base and Competitors
Table 54. Reddot Biotech Major Business
Table 55. Reddot Biotech Pulmonary Surfactant Product and Services
Table 56. Reddot Biotech Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Reddot Biotech Recent Developments/Updates
Table 58. XpressBio Basic Information, Manufacturing Base and Competitors
Table 59. XpressBio Major Business
Table 60. XpressBio Pulmonary Surfactant Product and Services
Table 61. XpressBio Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. XpressBio Recent Developments/Updates
Table 63. Creative Diagnostics Basic Information, Manufacturing Base and Competitors
Table 64. Creative Diagnostics Major Business
Table 65. Creative Diagnostics Pulmonary Surfactant Product and Services
Table 66. Creative Diagnostics Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Creative Diagnostics Recent Developments/Updates
Table 68. Nanjing Norris Pharm Technology Basic Information, Manufacturing Base and Competitors
Table 69. Nanjing Norris Pharm Technology Major Business
Table 70. Nanjing Norris Pharm Technology Pulmonary Surfactant Product and Services
Table 71. Nanjing Norris Pharm Technology Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Nanjing Norris Pharm Technology Recent Developments/Updates
Table 73. Windtree Therapeutics Basic Information, Manufacturing Base and Competitors
Table 74. Windtree Therapeutics Major Business
Table 75. Windtree Therapeutics Pulmonary Surfactant Product and Services
Table 76. Windtree Therapeutics Pulmonary Surfactant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Windtree Therapeutics Recent Developments/Updates
Table 78. Global Pulmonary Surfactant Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Pulmonary Surfactant Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Pulmonary Surfactant Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 81. Market Position of Manufacturers in Pulmonary Surfactant, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Pulmonary Surfactant Production Site of Key Manufacturer
Table 83. Pulmonary Surfactant Market: Company Product Type Footprint
Table 84. Pulmonary Surfactant Market: Company Product Application Footprint
Table 85. Pulmonary Surfactant New Market Entrants and Barriers to Market Entry
Table 86. Pulmonary Surfactant Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Pulmonary Surfactant Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Pulmonary Surfactant Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Pulmonary Surfactant Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Pulmonary Surfactant Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Pulmonary Surfactant Average Price by Region (2018-2023) & (USD/Unit)
Table 92. Global Pulmonary Surfactant Average Price by Region (2024-2029) & (USD/Unit)
Table 93. Global Pulmonary Surfactant Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Pulmonary Surfactant Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Pulmonary Surfactant Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Pulmonary Surfactant Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Pulmonary Surfactant Average Price by Type (2018-2023) & (USD/Unit)
Table 98. Global Pulmonary Surfactant Average Price by Type (2024-2029) & (USD/Unit)
Table 99. Global Pulmonary Surfactant Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Pulmonary Surfactant Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Pulmonary Surfactant Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Pulmonary Surfactant Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Pulmonary Surfactant Average Price by Application (2018-2023) & (USD/Unit)
Table 104. Global Pulmonary Surfactant Average Price by Application (2024-2029) & (USD/Unit)
Table 105. North America Pulmonary Surfactant Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Pulmonary Surfactant Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Pulmonary Surfactant Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Pulmonary Surfactant Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Pulmonary Surfactant Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Pulmonary Surfactant Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Pulmonary Surfactant Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Pulmonary Surfactant Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Pulmonary Surfactant Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Pulmonary Surfactant Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Pulmonary Surfactant Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Pulmonary Surfactant Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Pulmonary Surfactant Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Pulmonary Surfactant Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Pulmonary Surfactant Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Pulmonary Surfactant Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Pulmonary Surfactant Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Pulmonary Surfactant Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Pulmonary Surfactant Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Pulmonary Surfactant Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Pulmonary Surfactant Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Pulmonary Surfactant Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Pulmonary Surfactant Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Pulmonary Surfactant Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Pulmonary Surfactant Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Pulmonary Surfactant Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Pulmonary Surfactant Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Pulmonary Surfactant Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Pulmonary Surfactant Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Pulmonary Surfactant Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Pulmonary Surfactant Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Pulmonary Surfactant Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Pulmonary Surfactant Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Pulmonary Surfactant Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Pulmonary Surfactant Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Pulmonary Surfactant Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Pulmonary Surfactant Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Pulmonary Surfactant Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Pulmonary Surfactant Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Pulmonary Surfactant Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Pulmonary Surfactant Raw Material
Table 146. Key Manufacturers of Pulmonary Surfactant Raw Materials
Table 147. Pulmonary Surfactant Typical Distributors
Table 148. Pulmonary Surfactant Typical Customers
List of Figures
Figure 1. Pulmonary Surfactant Picture
Figure 2. Global Pulmonary Surfactant Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pulmonary Surfactant Consumption Value Market Share by Type in 2022
Figure 4. Synthetic Pulmonary Surfactants Examples
Figure 5. Animal Derived Surfactants Examples
Figure 6. Global Pulmonary Surfactant Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Pulmonary Surfactant Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. laboratory Examples
Figure 10. Others Examples
Figure 11. Global Pulmonary Surfactant Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Pulmonary Surfactant Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Pulmonary Surfactant Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Pulmonary Surfactant Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Pulmonary Surfactant Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Pulmonary Surfactant Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Pulmonary Surfactant by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Pulmonary Surfactant Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Pulmonary Surfactant Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Pulmonary Surfactant Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Pulmonary Surfactant Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Pulmonary Surfactant Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Pulmonary Surfactant Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Pulmonary Surfactant Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Pulmonary Surfactant Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Pulmonary Surfactant Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Pulmonary Surfactant Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Pulmonary Surfactant Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Pulmonary Surfactant Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Pulmonary Surfactant Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Pulmonary Surfactant Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Pulmonary Surfactant Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Pulmonary Surfactant Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Pulmonary Surfactant Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Pulmonary Surfactant Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Pulmonary Surfactant Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Pulmonary Surfactant Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Pulmonary Surfactant Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Pulmonary Surfactant Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Pulmonary Surfactant Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Pulmonary Surfactant Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Pulmonary Surfactant Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Pulmonary Surfactant Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Pulmonary Surfactant Consumption Value Market Share by Region (2018-2029)
Figure 53. China Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Pulmonary Surfactant Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Pulmonary Surfactant Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Pulmonary Surfactant Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Pulmonary Surfactant Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Pulmonary Surfactant Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Pulmonary Surfactant Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Pulmonary Surfactant Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Pulmonary Surfactant Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Pulmonary Surfactant Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Pulmonary Surfactant Market Drivers
Figure 74. Pulmonary Surfactant Market Restraints
Figure 75. Pulmonary Surfactant Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Pulmonary Surfactant in 2022
Figure 78. Manufacturing Process Analysis of Pulmonary Surfactant
Figure 79. Pulmonary Surfactant Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Boehringer Ingelheim
AbbVie
Lyomark Pharma
Tekzima (Noargen)
ONY Biotech
Abbott
Aviva Systems Biology
LSBio
Biomatik
Biorbyt
Reddot Biotech
XpressBio
Creative Diagnostics
Nanjing Norris Pharm Technology
Windtree Therapeutics
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now